Fig. 4From: Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladderKaplan–Meier analyses of disease-specific survival (DSS) and metastasis-free survival (MeFS) according to ZSCAN4 immunoexpression status. Low expression of ZSCAN4 was significantly associated with worse DSS and MeFS both in UTUC (A and B) and UBUC (C and D)Back to article page